Johnson and Johnson begins human safety preliminaries Kumar Jeetendra | July 30, 2020 Johnson & Johnson on Thursday kicked off US human safety trials because of its COVID-19 vaccine after releasing details of a research in monkeys that showed its best-performing vaccine candidate offered strong defense in a single dose. When subjected to this virus, six out of six animals who obtained the vaccine candidate proved completely protected …
Stage 2 human preliminary of Oxford antibody may begin from August 26 in Pune Kumar Jeetendra | August 25, 2020 The trial may start from Wednesday, said a top official of the institute, among the 17 sites selected for the phase two human trials in the nation by Serum Institute of India (SII). “To begin with we’ve identified five volunteers who will undergo COVID-19 and antibodies test. Those whose reports are negative will be shortlisted …
